Received Aug 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 93N4J | — |
Shingrix diluted with sterile water administered; Shingrix diluted with sterile water administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 59-year-old female patient who received Herpes zoster (Shingrix) (batch number 93N4J, expiry date 25-APR-2027) for prophylaxis. On 23-JUL-2025, the patient received Shingrix. On 23-JUL-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: Shingrix diluted with sterile water administered) and inappropriate dose of vaccine administered (Verbatim: Shingrix diluted with sterile water administered). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 28-JUL-2025 The registered nurse explained that on 23-Jul-2025, they gave a Shingrix vaccine in the office, but it was not diluted with the diluent that comes in the box, but with sterile water which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. Consented to follow up.